TherapeuticsMD, Inc. 4
4 · TherapeuticsMD, Inc. · Filed May 22, 2015
Insider Transaction Report
Form 4
Krassan Mitchell
EVP, Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2015-05-20$0.19/sh+60,000$11,244→ 60,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-05-20−60,000→ 105,703 totalExercise: $0.19From: 2011-10-04Exp: 2020-05-01→ Common Stock (60,000 underlying) - Sale
Common Stock
2015-05-20$6.56/sh−60,000$393,354→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.63 to $6.50, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.